Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials
Open accessThe DOI matches its Crossref record; 88 of the 94 references it cites were found in a registry or an index.
Abstract
Arthritis patients often take fish oil supplements to alleviate symptoms, but limited evidence exists regarding their efficacy. The objective was to evaluate whether marine oil supplements reduce pain and/or improve other clinical outcomes in patients with arthritis. Six databases were searched systematically (24 February 2015). We included randomized trials of oral supplements of all marine oils compared with a control in arthritis patients. The internal validity was assessed using the Cochrane Risk of Bias tool and heterogeneity was explored using restricted maximum of likelihood (REML)-based meta-regression analysis. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to rate the overall quality of the evidence. Forty-two trials were included; 30 trials reported complete data on pain. The standardized mean difference (SMD) suggested a favorable effect (−0.24; 95% confidence interval, CI, −0.42 to −0.07; heterogeneity, I2 = 63%. A significant effect was found in patients with rheumatoid arthritis (22 trials; −0.21; 95% CI, −0.42 to −0.004) and other or mixed diagnoses (3 trials; −0.63; 95% CI, −1.20 to −0.06), but not in osteoarthritis patients (5 trials; −0.17; 95% CI, −0.57–0.24). The evidence for using marine oil to alleviate pain in arthritis patients was overall of low quality, but of moderate quality in rheumatoid arthritis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Risk of bias summary figure. : adequate methodology, : unclear methodology, : inadequate methodology. Risk of outcome reporting bias was not assessed for Vargová et al. (1998) [49], since only the abstract was available in English, and the rest of the article was not in English. Therefore, it was not considered appropriate to assess outcome reporting bias based only on the abstract of a full article.](https://figures.cochat.ai/paper-figures/5da8481abab24c15953ede5cd20bb38b/marine-oil-supplements-for-arthritis-pain-a-systematic-review-and-meta-analysis-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the multiple purported benefits, systematic reviews and meta-analyses have found the clinical evidence for OM-3 dietary supplements in these health conditions to be insufficient, inconsistent, or negative [34–39].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“For example, a systematic review and meta-analysis of 42 randomized clinical trials of OM-3 dietary supplementation for arthritis noted a moderate benefit among patients with rheumatoid arthritis, but insufficient evidence to determine the effect in other types of arthritis [34].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [34]
In the citing paper
“Despite the multiple purported clinical benefits, the published evidence for OM-3 dietary supplements is generally insufficient, inconsistent, or negative.”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [34]
In the citing paper
“For example, a systematic review and meta-analysis of 42 randomized clinical trials of OM-3 dietary supplementation for arthritis noted a moderate benefit among patients with rheumatoid arthritis, but insufficient evidence to determine the effect in other types of arthritis [34].”
From Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review (2020) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Distribution Theory for Glass's Estimator of Effect Size and Related Estimators
Hedges, L. V. (1981) · Journal of Educational Statistics · doi:10.2307/1164588 · Cited by 5,695 · cited 1×
“A correction was applied by default by calculating Hedges’s g [30] and the variance (SE2) was calculated based on the SMD and number of patients in each group [31].”
MethodThe Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 1×
“Trials with low internal validity may distort the results from meta-analyses [26], so trials were assessed using the Cochrane Risk of Bias tool [27].”
Method
Research works printed but not linked: 11
- Darlington L.G. Ramsey N.W. Olive oil for rheumatoid patients? Br. J. Rheumatol. 1987 26 129
- Tulleken J.E. Limburg P.C. Muskiet F.A.J. Kazemier K.M. Van Rijswijk M.H. A Comparison between the Effects of Fish Oil Ethyl Esters and Fish Oil Triglycerides in Rheumatoid Arthritis, Long Chain Omega-3 Polyunsaturated Fatty Acids in Rheumatoid Arthritis Thesis Rijksuniversiteit Groningen Groningen, The Netherlands 1991
- Tulleken J.E. Limburg P.C. Wassenaar W. Van Rijswijk M.H. Nonsteroidal Anti-Inflammatory Drug Demand during Fish Oil Treatment in Rheumatoid Arthritis, Long Chain Omega-3 Polyunsaturated Fatty Acids in Rheumatoid Arthritis Thesis Rijksuniversiteit Groningen Groningen, The Netherlands 1991
- Nielsen G.L. Faarvang K.L. Thomsen B.S. Teglibjaerg K.L. Ernst E. Effects of supplementation with n-3 fatty acids on clinical disease variables in patients with rheumatoid arthritis Eur. J. Clin. Invest. 1991 21 67 1459173
- Araújo C.A. Moraes-Fontes M.F. Santos L. Riso N. Omega-3 fatty acids and mediterranean diet as complimentary therapies for rheumatoid arthritis Arthritis Rheumatol. 2014 66 S1050
- Hernández-Cruz B. Alcocer-Varela J. Cardiel M.H. Omega-3 fatty acids supplementation in Mexican patients with rheumatoid arthritis with standard treatment. A blinded, randomized, placebo controlled, one year, clinical trial Arthritis Rheum. 1998 41 S155
- Kremer J. Larence D. Jubiz W. Digarcomo R. Rynes R. Bartholomew L. Different doses of fish-oil fatty acid supplementation in rheumatoid arthritis ra a prospective double-blinded randomized study Arthritis Rheum. 1988 31 S303
- Kremer J.M. Lawrence D.A. Stocker R.S. Rynes R.I. Parhami N. Greenstein N.S. Petrillo G.F. Simon L.S. Robinson D.W. Clinical, immunological and nsaid sparing effects of fish-oil (fo) in patients with active rheumatoid-arthritis (ra)-a long-term prospective randomized double-blind-study Arthritis Rheum. 1993 36 S56
- Lau C.S. McMahon H. Morley K.D. Belch J.J.F. Effects of maxepa on non-steroidal anti-inflammatory drug usage in patients with mild rheumatoid arthritis Br. J. Rheumatol. 1991 30 137 8220938
- Kolahi S. Haghjoo A.G. Effect of fish oil supplements on serum paraoxonase activity in patients with rheumatoid arthritis Rheumatology (Oxf., Engl.) 2012 51 i31 22924372
- Yazdanpanah P. Mohamadi H. Sadeghi H. Ghaffarian Shirazi H. Arjmand A. Survey of omega-3 effects on morning stiffness in osteoarthritis of the knee Pain Pract. 2014 14 126
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
“505 Systematic reviews of the use of EPA and DHA in patients with rheumatoid arthritis con- 506 firm a reduction in pain [163,164].”
BackgroundOmega-6 fatty acids and inflammation
Innes, J. K., & Calder, P. C. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.03.004 · Cited by 929
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
“Recent systematic reviews and meta-analyses have highlighted the benefits of EPA+DHA on arthritic pain((160,161)).”
BackgroundModern-day environmental factors in the pathogenesis of osteoarthritis
Berenbaum, F., Wallace, I. J., Lieberman, D. E., & Felson, D. T. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0073-x · Cited by 323
Gwinnutt, J. M., Wieczorek, M., Balanescu, A., Bischoff-Ferrari, H. A., Boonen, A., Cavalli, G., de Souza, S., de Thurah, A., Dorner, T. E., Moe, R. H., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-222020 · Cited by 263
Metadata
- Authors
- Senftleber, N., Nielsen, S., Andersen, J., Bliddal, H., Tarp, S., Lauritzen, L., Furst, D., Suarez-Almazor, M., Lyddiatt, A., & Christensen, R.
- Affiliations
- University of Copenhagen (DK)
- Frederiksberg Hospital (DK)
- Division of Rheumatology, University of California, Los Angeles, CA 90095, USA
- The University of Texas MD Anderson Cancer Center (US)
- Cochrane Canada (CA)
- Corresponding author
- Christensen, Robin
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-01-06
- Volume
- 9
- Issue
- 1
- Pages
- 42
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC5295086
- OpenAlex
- W2570262414
- Cited by
- 114
- References
- 94
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 16 · 2018: 14 · 2017: 4
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- The Oak Foundation ((indirect funding))
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24 AR053593 (M.E. Suarez-Almazor received a Midcareer Investigator Award))
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- fish oil, arthritis, rheumatoid arthritis, osteoarthritis, analgesia, omega-3 fatty acids, dietary supplements
- MeSH terms
- Arthritis, Rheumatoid, Docosahexaenoic Acids, Fish Oils, Humans, Inflammation, Osteoarthritis, Pain, Eicosapentaenoic Acid, Randomized Controlled Trials as Topic, Databases, Factual, Treatment Outcome, alpha-Linolenic Acid, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.